Jiansong Huang

2.5k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Jiansong Huang is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiansong Huang has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 26 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Jiansong Huang's work include Acute Myeloid Leukemia Research (20 papers), Platelet Disorders and Treatments (9 papers) and Cell Adhesion Molecules Research (7 papers). Jiansong Huang is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Platelet Disorders and Treatments (9 papers) and Cell Adhesion Molecules Research (7 papers). Jiansong Huang collaborates with scholars based in China, United States and Canada. Jiansong Huang's co-authors include Zhengcui Wu, Feng Gao, Jie Jin, Xiangyu Wang, Xia Wang, Jinghan Wang, Wenle Ye, Huafeng Wang, Shujuan Huang and Jiajia Pan and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Jiansong Huang

58 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting

2019 269 citations Jiansong Huang, Xia Li et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiansong Huang China	19	850	749	501	356	207	59	2.0k
Yuxuan Wang United States	24	964 1.1×	436 0.6×	815 1.6×	26 0.1×	468 2.3×	80	3.1k
Xiaojuan Wang China	19	412 0.5×	372 0.5×	806 1.6×	24 0.1×	201 1.0×	46	1.9k
Hyun-Jung Choi South Korea	20	349 0.4×	251 0.3×	757 1.5×	113 0.3×	849 4.1×	46	2.6k
Cunji Gao China	25	48 0.1×	178 0.2×	512 1.0×	329 0.9×	644 3.1×	46	1.8k
Xi Hu China	24	107 0.1×	245 0.3×	639 1.3×	33 0.1×	150 0.7×	75	1.7k
Xiaoli Deng China	22	111 0.1×	277 0.4×	536 1.1×	34 0.1×	119 0.6×	73	1.4k
Xiangxiang Zhou China	25	98 0.1×	98 0.1×	1.1k 2.1×	63 0.2×	140 0.7×	124	2.1k
Yanzhu Yang United States	14	411 0.5×	70 0.1×	516 1.0×	106 0.3×	318 1.5×	24	1.4k
Xiaofei Zhou United States	20	49 0.1×	110 0.1×	431 0.9×	69 0.2×	93 0.4×	79	1.2k

Countries citing papers authored by Jiansong Huang

Since Specialization

Citations

This map shows the geographic impact of Jiansong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiansong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiansong Huang more than expected).

Fields of papers citing papers by Jiansong Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiansong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiansong Huang. The network helps show where Jiansong Huang may publish in the future.

Co-authorship network of co-authors of Jiansong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiansong Huang. A scholar is included among the top collaborators of Jiansong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiansong Huang. Jiansong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Xiangjie, Min Xin, Xia Li, et al.. (2025). α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment. Blood Advances. 9(5). 1185–1201. 2 indexed citations

Xu, Wangshu, Zhiwei Rong, Wenping Ma, et al.. (2024). Improving the classification of multiple sclerosis and cerebral small vessel disease with interpretable transfer attention neural network. Computers in Biology and Medicine. 176. 108530–108530. 1 indexed citations

Lei, Tao, Yazhuo Wang, Yuchen Zhang, et al.. (2024). Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy. Leukemia. 38(12). 2517–2543. 45 indexed citations

Wang, Shuqiang, et al.. (2024). Gold nanoparticles supported onto zwitterionic polymer capillary monoliths meant for efficient enrichment of microcystins in water. Talanta. 286. 127508–127508. 1 indexed citations

Ye, Wenle, Xin Huang, Jiansong Huang, et al.. (2023). Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. British Journal of Haematology. 202(3). 566–577. 10 indexed citations

Huang, Jiansong, et al.. (2023). Mice Lacking α-Actinin-1 in Megakaryocytes Display the Feature of Thrombocytopenia and Impair Platelet Functions. Blood. 142(Supplement 1). 2576–2576. 1 indexed citations

Mao, Shihui, Qian Yu, Wenwen Wei, et al.. (2023). FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of Hematology. 102(3). 583–595. 7 indexed citations

Huang, Jiansong, et al.. (2023). Structure, signal transduction, activation, and inhibition of integrin αIIbβ3. Thrombosis Journal. 21(1). 18–18. 8 indexed citations

Mao, Shihui, Jiajia Pan, Wenwen Wei, et al.. (2023). CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML. Cancer Biomarkers. 37(3). 133–145. 4 indexed citations

10.

Ye, Wenle, Xin Huang, Xia Li, et al.. (2023). The ferroptosis landscape in acute myeloid leukemia. Aging. 15(22). 13486–13503. 6 indexed citations

11.

Huang, Jiansong, Bowen Jiang, Guo‐Wei Li, et al.. (2022). m6A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation. Cell Reports. 41(8). 111693–111693. 22 indexed citations

12.

Zhu, Kongkai, Zhangbiao Long, Huimin Zhang, et al.. (2022). Targeting the RT loop of Src SH3 in Platelets Prevents Thrombosis without Compromising Hemostasis. Advanced Science. 9(7). e2103228–e2103228. 7 indexed citations

13.

Lin, Xiangjie, Jinghan Wang, Xin Huang, et al.. (2021). Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study. Aging. 13(7). 10468–10489. 35 indexed citations

14.

Li, Fenglin, Xiang Zhang, Shihui Mao, et al.. (2021). MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway. EBioMedicine. 69. 103441–103441. 10 indexed citations

15.

Zhang, Yan, Yuanfei Shi, Huafei Shen, et al.. (2021). The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma. Cancer Cell International. 21(1). 573–573. 5 indexed citations

16.

Huang, Jiansong, Xin Huang, Xia Li, et al.. (2021). Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis. Frontiers of Medicine. 16(3). 416–428. 11 indexed citations

17.

Xia, Lin, Wenle Ye, Jiansong Huang, et al.. (2020). Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia. Cancer Biomarkers. 28(2). 151–158. 21 indexed citations

18.

Huang, Shujuan, Jiajia Pan, Jing Jin, et al.. (2019). Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. Cancer Letters. 461. 132–143. 18 indexed citations

19.

Wei, Dan, Nannan Gao, Lei Li, et al.. (2017). α-Tubulin Acetylation Restricts Axon Overbranching by Dampening Microtubule Plus-End Dynamics in Neurons. Cerebral Cortex. 28(9). 3332–3346. 48 indexed citations

20.

Huang, Jiansong, et al.. (2015). Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy. Journal of Hematology & Oncology. 8(1). 62–62. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact